Analytical performance evaluation of the Mindray enzymatic assay for hemoglobin A


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
29 05 2024
Historique:
received: 19 10 2023
accepted: 27 05 2024
medline: 30 5 2024
pubmed: 30 5 2024
entrez: 29 5 2024
Statut: epublish

Résumé

Hemoglobin A

Identifiants

pubmed: 38811684
doi: 10.1038/s41598-024-63261-y
pii: 10.1038/s41598-024-63261-y
doi:

Substances chimiques

Glycated Hemoglobin 0
hemoglobin A1c protein, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

12289

Subventions

Organisme : Medical Science and Technology Foundation of Guangdong Province
ID : B2021064

Informations de copyright

© 2024. The Author(s).

Références

Braga, F., Dolci, A., Mosca, A. & Panteghini, M. Biological variability of glycated hemoglobin. Chim. Clin. Acta 411, 1606–1610 (2010).
doi: 10.1016/j.cca.2010.07.030
Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329, 977–986 (1993).
doi: 10.1056/NEJM199309303291401
U.K. Prospective Diabetes Study (UKPDS) Group. Intensive bloodglucose control with sulphonyl ureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998(352), 837–853 (1998).
Sacks, D. B. et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Diabetes Care. 34(6), e61-99 (2011).
doi: 10.2337/dc11-9998 pubmed: 21617108 pmcid: 3114322
Gillett, M. J. International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes. Diabetes Care. 32, 1327–1334 (2009).
doi: 10.2337/dc09-9033
Weykamp, C., John, W. G. & Mosca, A. A review of the challenge in measuring hemoglobin A1c. J. Diabetes Sci. Technol. 3, 439–445 (2009).
doi: 10.1177/193229680900300306 pubmed: 20144280 pmcid: 2769874
Song, Y. et al. Comparability of different methods of glycated hemoglobin measurement for samples of patients with variant and non-variant hemoglobin. Clin. Chim. Acta. 533, 168–174 (2022).
doi: 10.1016/j.cca.2022.06.024 pubmed: 35780822
Little, R. R. & Roberts, W. L. A review of variant hemoglobins interfering with hemoglobin A1c measurement. J. Diabetes Sci. Technol. 3, 446–451 (2009).
doi: 10.1177/193229680900300307 pubmed: 20144281 pmcid: 2769887
Camargo, J. L., Stifft, J. & Gross, J. L. The effect of aspirin and vitamins C and E on HbA1c assays. Clin. Chim. Acta. 372, 2069 (2006).
doi: 10.1016/j.cca.2006.03.031
Kaiser, P. et al. HbA1c: EQA in Germany, Belgium and the Netherlands using fresh whole blood samples with target values assigned with the IFCC reference system. Clin. Chem. Lab. Med. 54(11), 1769–1775 (2016).
doi: 10.1515/cclm-2016-0123 pubmed: 27171390
Little, R. R. et al. Effects of hemoglobin (Hb) E and HbD traits on measurements of glycated Hb (HbA1c) by 23 methods. Clin. Chem. 54(8), 1277–1282 (2008).
doi: 10.1373/clinchem.2008.103580 pubmed: 18556332
Kang, F., Li, W., Lou, Y. & Shan, Z. Application of biological variation and sigma metrics to evaluate the performance of HbA1c in external quality assessment. Scand. J. Clin. Lab. Invest. 82(5), 398–403 (2022).
doi: 10.1080/00365513.2022.2100822 pubmed: 35872643
Loh, T. P. et al. Setting analytical performance specifications using HbA1c as a model measurand. Clin. Chim. Acta. 523, 407–414 (2021).
doi: 10.1016/j.cca.2021.10.016 pubmed: 34666026
Tang, M. et al. The impact of carbamylation and anemia on HbA1c’s association with renal outcomes in patients with diabetes and chronic kidney disease. Diabetes Care. 46(1), 130–137 (2023).
doi: 10.2337/dc22-1399 pubmed: 36399777
Zechmeister, B. et al. Analytical interference of 33 different hemoglobin variants on HbA1c measurements comparing high-performance liquid chromatography with whole blood enzymatic assay: A multi-center study. Clin. Chim. Acta. 531, 145–151 (2022).
doi: 10.1016/j.cca.2022.03.028 pubmed: 35378091
Jacobs, J. W., Gisriel, S. D., Iyer, K., Hauser, R. G. & El-Khoury, J. M. Unexpectedly low hemoglobin A1c in a patient with chronic lymphocytic leukemia. Clin. Chim. Acta. 531, 91–93 (2022).
doi: 10.1016/j.cca.2022.03.012 pubmed: 35351433
Teodoro-Morrison, T. et al. Evaluation of a next generation direct whole blood enzymatic assay for hemoglobin A1c on the ARCHITECT c8000 chemistry system. Clin. Chem. Lab. Med. 53(1), 125–132 (2015).
doi: 10.1515/cclm-2014-0310 pubmed: 25153395

Auteurs

Mingyang Li (M)

Department of Laboratory Medicine, Peking University Shenzhen Hospital, Shenzhen, Guangdong, China.

Xiongjun Wu (X)

Department of Laboratory Medicine, Shenzhen Integrated Traditional Chinese and Western Medicine Hospital, Shenzhen, China.

Weijie Xie (W)

Department of Laboratory Medicine, Peking University Shenzhen Hospital, Shenzhen, Guangdong, China.

Yu Zeng (Y)

Department of Laboratory Medicine, Peking University Shenzhen Hospital, Shenzhen, Guangdong, China.

Hui Wang (H)

Department of Clinical Laboratory, Wuhan Asia General Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, China.

Han Chen (H)

Department of Clinical Laboratory, Wuhan Asia General Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, China.

Anping Xu (A)

Department of Laboratory Medicine, Peking University Shenzhen Hospital, Shenzhen, Guangdong, China. anpingxu2023sci@163.com.

Helu Liu (H)

Department of Laboratory Medicine, Shenzhen Integrated Traditional Chinese and Western Medicine Hospital, Shenzhen, China. 185766321@qq.com.

Ling Ji (L)

Department of Laboratory Medicine, Peking University Shenzhen Hospital, Shenzhen, Guangdong, China. 1120303921@qq.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH